NovaBay Pharmaceuticals (NBY) Stock Climbs On Launch

NovaBay Pharmaceuticals NBY Stock News

First and foremost, any time a new product is launched, it opens the door to potential revenue opportunities. So, this product launch is yet another opportunity for NBY to drive revenue.

However, the excitement goes further than that. So far, the launch of AveNova Direct has proven to be an incredible success. Not only is the company seeing decent sales volume, customers are loving it. This can be seen by the well over 4-star review average.

Considering the fact that is a master at bundling like-products or products that should be sold together, we should see this product included in the related products section, only expanding its potential to see strong sales.

All in all, the recent news with multiple product launches means that NBY is turning a corner. It is ramping up commercialization and focusing on strong revenue growth. There’s plenty to be excited about in that.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story!

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Pages: 1 2

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.